Transcription of Annex 3 - WHO
{{id}} {{{paragraph}}}
Example: marketing
Annex 3 - WHO
119 Annex 3 Good manufacturing practices: guidelines on validation Background The need for revision of the published World Health Organization (WHO) Supplementary guidelines on good manufacturing practices: validation (1) was identified by the Prequalification of Medicines Programme and a first draft document was circulated for comment in early 2013. The focus, at that time, was revision of the appendix on Non-sterile process validation (Appendix 7) (2), which had been revised and was adopted by the ECSPP at its Forty-ninth meeting in October 2014 (3). The overarching text presented in this Annex constitutes the general principles of the new guidance on validation .
control of starting materials and finished pharmaceutical products, as well as other areas such as GCP. Although the principles addressed in this guideline are applicable, qualification and validation of specific products, methods, processes and systems, such as bioanalytical methods, and manufacturing
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: